Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
7. Covidien discontinues surgical staples following patient injuries, deaths
Covidien discontinues the Duet TRS surgical staples that it recalled earlier this year following reports of patients injuries and deaths.
6. Ex-ArthroCare execs arrested for alleged roles in $400M securities fraud
A pair of former ArthroCare senior executives are in the hot seat for their alleged roles in a securities fraud scheme that cost shareholders $400 million.
5. FDA warns Medtronic on neuromodulation complaint mishandling
The FDA warns Medtronic for mishandling complaints for its SynchroMed II implantable drug pumps, ordering a prompt meeting and a follow-up visit.
4. Medtronic’s CRM optimism contrasts with St. Jude’s conservatism
Medtronic is hopeful for the U.S. cardiac rhythm management arena, noting continued stabilization in the market, despite comments from cross-town rival St. Jude that the market has further to go before hitting bottom.
3. New warnings for St. Jude’s next-gen defibrillator leads
New warnings about St. Jude Medical’s next-generation defibrillator leads suggest that the company’s Durata and Riata ST Optim products may be prone to defects similar to the abrasion that spurred the Riata recall.
2. FDA asks J&J’s DePuy to recall unused custom implants
Johnson & Johnson subsidiary DePuy Orthopedics recalls all unused custom implants, a product line the company discontinued after receiving an FDA warning letter late last year.
1. GI Dynamics CEO says FDA decision could speed up U.S. launch
body
